NZ622598A - Treating acute decompensated heart failure with relaxin - Google Patents

Treating acute decompensated heart failure with relaxin

Info

Publication number
NZ622598A
NZ622598A NZ622598A NZ62259809A NZ622598A NZ 622598 A NZ622598 A NZ 622598A NZ 622598 A NZ622598 A NZ 622598A NZ 62259809 A NZ62259809 A NZ 62259809A NZ 622598 A NZ622598 A NZ 622598A
Authority
NZ
New Zealand
Prior art keywords
relaxin
heart failure
treating acute
decompensated heart
acute decompensated
Prior art date
Application number
NZ622598A
Inventor
Martha Jo Whitehouse
Gad Cotter
Elaine Unemori
Sam L Teichman
Dennis R Stewart
Original Assignee
Corthera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corthera Inc filed Critical Corthera Inc
Priority to NZ701038A priority Critical patent/NZ701038A/en
Publication of NZ622598A publication Critical patent/NZ622598A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Discloses the use of active H2 relaxin in the manufacture of a medicament for reducing congestion in a hypertensive or normotensive human subject with acute heart failure, wherein the N-terminal fragement brain natriuretic peptide (NT-BNP) levels are lower in subjects who were administered the medicament comprising relaxin than in subjects who were administered a placebo.
NZ622598A 2008-05-16 2009-05-15 Treating acute decompensated heart failure with relaxin NZ622598A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ701038A NZ701038A (en) 2008-05-16 2009-05-15 Treating acute decompensated heart failure with relaxin

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12788908P 2008-05-16 2008-05-16
US19054508P 2008-08-28 2008-08-28
US20124008P 2008-12-08 2008-12-08
US16433309P 2009-03-27 2009-03-27
NZ61281509 2009-05-15

Publications (1)

Publication Number Publication Date
NZ622598A true NZ622598A (en) 2014-12-24

Family

ID=52465011

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ622598A NZ622598A (en) 2008-05-16 2009-05-15 Treating acute decompensated heart failure with relaxin

Country Status (1)

Country Link
NZ (1) NZ622598A (en)

Similar Documents

Publication Publication Date Title
IL247351A0 (en) Pharmaceutically active human h2 relaxin for use as a medicament for treating dyspnea associated with acute heart failure
MX343360B (en) Peptide conjugates of glp-1 receptor agonists and gastrin and their use.
GEP20176629B (en) Glucagon/glp-1 receptor co-agonists
NZ707292A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
MX2012002449A (en) Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency.
IL201479A (en) Use of tapentadol for the manufacture of a medicament for the treatment of pain
EA201170149A1 (en) NEW ANALOGUES INSULIN OF PROLONGED ACTIVITY
MX2010005331A (en) Compositions and methods for treating purpura.
MX336145B (en) Method of treating chronic heart failure.
MX2020008041A (en) Method for delivering drug to muscle.
MX2013002244A (en) Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2.
MX2014005351A (en) Glp-1 receptor agonist peptide gastrin conjugates.
MX2009007085A (en) Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof.
NZ592612A (en) Vasoactive intestinal peptide (VIP) Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-X for the treatment of kidney disorders
HK1143066A1 (en) Ranolazine for elevated brain-type natriuretic peptide
NZ608266A (en) Administration of lorcaserin to individuals with renal impairment
WO2011057027A3 (en) Method for treating heart failure with stresscopin-like peptides
WO2010093993A3 (en) Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
NZ590469A (en) Treatment of rheumatoid arthritis with human beta defensins (1-4)
MX2010008280A (en) Composition for stimulating natural killer cell activity.
NZ622598A (en) Treating acute decompensated heart failure with relaxin
EP1997503A3 (en) Treatment of melanoma with alpha thymosin peptides
AU2016219717A1 (en) Treating dyspnea associated with acute heart failure with relaxin
WO2012074559A3 (en) Treatment of non-proliferative cystic disease
AU2013201629B2 (en) Treating dyspnea associated with acute heart failure with relaxin

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 MAY 2016 BY BALDWINS INTELLECTUAL PROPERTY

Effective date: 20150330

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 MAY 2017 BY CPA GLOBAL

Effective date: 20160405

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 MAY 2018 BY CPA GLOBAL

Effective date: 20170418

LAPS Patent lapsed